|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Hospital Vozandez Merck |
|---|---|
| Information provided by: | Hospital Vozandez |
| ClinicalTrials.gov Identifier: | NCT00565682 |
Purpose
To test the analgesic efficacy of etoricoxib used before a surgical procedure compared to the already known effect when administered after such a procedure. Patient will be receiving either etoricoxib or the respective placebo one hour before surgery, then two hours after those receiving the active will receive placebo and those that received placebo will be given etoricoxib. Pain score measurements will be performed sequentially. Rescue medication will be available all the time.
| Condition | Intervention | Phase |
|---|---|---|
|
Laparoscopic Surgery for Appendicitis Laparoscopic Surgery for Cholecystitis Laparoscopic Surgery for Ovarian Cysts |
Drug: etoricoxib 120 mg |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Pain Post Abdominal Laparoscopy Prevention With Arcoxia |
| Enrollment: | 60 |
| Study Start Date: | April 2006 |
| Study Completion Date: | December 2006 |
| Arms | Assigned Interventions |
|---|---|
|
A: Experimental
Etoricoxib 120 mg
|
Drug: etoricoxib 120 mg
etoricoxib 120 mg, tablet, orally, OD
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Responsible Party: | Hospital Vozandez ( Eduardo Noboa ) |
| Study ID Numbers: | DOLAAR |
| Study First Received: | November 29, 2007 |
| Last Updated: | November 29, 2007 |
| ClinicalTrials.gov Identifier: | NCT00565682 History of Changes |
| Health Authority: | Ecuador: Public Health Ministry |
|
Gallbladder Diseases Anti-Inflammatory Agents Gastrointestinal Diseases Gonadal Disorders Pain Ovarian Diseases Genital Diseases, Female Acalculous Cholecystitis Biliary Tract Diseases Appendicitis Anti-Inflammatory Agents, Non-Steroidal Analgesics Etoricoxib |
Cyclooxygenase Inhibitors Cholecystitis Endocrine System Diseases Intestinal Diseases Cysts Digestive System Diseases Analgesics, Non-Narcotic Endocrinopathy Peripheral Nervous System Agents Gastroenteritis Antirheumatic Agents Ovarian Cysts |
|
Anti-Inflammatory Agents Gallbladder Diseases Molecular Mechanisms of Pharmacological Action Gastrointestinal Diseases Gonadal Disorders Physiological Effects of Drugs Ovarian Diseases Genital Diseases, Female Sensory System Agents Acalculous Cholecystitis Therapeutic Uses Biliary Tract Diseases Appendicitis Anti-Inflammatory Agents, Non-Steroidal Analgesics |
Etoricoxib Cyclooxygenase Inhibitors Cholecystitis Endocrine System Diseases Enzyme Inhibitors Cysts Intestinal Diseases Pharmacologic Actions Cecal Diseases Adnexal Diseases Neoplasms Digestive System Diseases Analgesics, Non-Narcotic Peripheral Nervous System Agents Antirheumatic Agents |